Suspected nonfatal drug overdoses during COVID-19 : archived provisional data report : March through September 2020

Details

• Corporate Authors:
  National Center for Injury Prevention and Control (U.S.)
• Description:
  The data report below comes from CDC’s DOSE system. The report displays total ED visits, ED visit counts for suspected overdoses, and overdose rates overall and by 42 states, including the District of Columbia, through September 2020. During the first several months of the COVID-19 pandemic, the number of total ED visits across the United States substantially declined; however, nonfatal overdoses did not decline at a similar pace.
  
  There are several important caveats to consider when viewing the figures included in this report. During the COVID-19 pandemic, states onboarded new facilities that began sharing data; also, some facilities stopped sharing data during this period. Thus, the number of facilities was not constant over this time period. In addition, states collaborated with existing facilities to increase the proportion of ED visits that contained diagnosis codes, which facilitates the identification of overdose-related visits. Caution is warranted in interpreting counts, rates, and comparisons to previous years due to these data issues.-
  
  Publication date from document properties.
  
  COVID-19-Nonfatal-Drug-Overdose-Data-508c.pdf
  
  
• Subjects:
  Drug Overdose Prescription Drug Misuse Prescription Drugs Public Health Surveillance
• Document Type:
  Pamphlet (or booklet)
• Name as Subject:
  U.S. Drug Overdose Surveillance and Epidemiology (DOSE) System.
• Place as Subject:
  United States
• Pages in Document:
  45 unnumbered pages
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:efb8d78b107ef06fb556bab5ed78c7dc379d49529657b798f33897d515f8173a
• Download URL:
  https://stacks.cdc.gov/view/cdc/123873/cdc_123873_DS1.pdf
• File Type:
  [PDF - 35.73 MB ]